Table 1 Clinical characteristics of AIS patients.
Characteristics | Total patients (n = 116) | HT patients (n = 36) | nHT patients(n = 80) | t/Z/χ2 | P |
|---|---|---|---|---|---|
Age (years), M(Q1, Q3) | 58.00 (51.00, 70.00) | 58.00 (51.00, 70.25) | 57.50 (51.75, 69.25) | 0.093 | 0.929 |
Gender | 0.408 | 0.523 | |||
Male (%) | 79 (68.10) | 26 (72.22) | 53 (66.25) | ||
Female (%) | 37 (31.90) | 10 (27.78) | 27 (33.75) | ||
Weight (Kg), M(Q1, Q3) | 70.00 (59.75, 75.00) | 70.00 (62.00, 75.00) | 69.50 (57.75, 75.22) | 0.156 | 0.876 |
BMI, M(Q1, Q3) | 24.95 (22.51, 26.95) | 25.37 (23.23, 26.57) | 24.86 (22.26, 27.25) | 0.280 | 0.779 |
Hypertension (%) | 91(79.45) | 25 (69.44) | 66 (82.50) | 2.503 | 0.114 |
Diabetes (%) | 82(70.69) | 26 (72.22) | 56 (70.00) | 0.059 | 0.808 |
NIHSS on admission, M(Q1, Q3) | 11.50 (6.00, 15.00) | 14.50 (12.00, 17.00) | 9.00 (4.00, 13.25) | 4.775 | < 0.001 |
ASPECTS on admission, M(Q1, Q3) | 12.00 (9.00, 13.00) | 9.00(7.00, 11.25) | 13.00 (11.00, 13.00) | − 5.614 | < 0.001 |
SBP (mmHg), M(Q1, Q3) | 152.00 (137.75, 162.00) | 147.50 (131.50, 157.00) | 156.50 (141.00, 162.25) | − 2.254 | 0.024 |
DBP (mmHg), Mean ± SD | 91.37 ± 14.64 | 88.22 ± 15.54 | 92.79 ± 14.09 | − 1.563 | 0.121 |
GLU (mmol/L), M(Q1, Q3) | 6.76 (5.77, 9.05) | 8.26 (6.48, 11.05) | 6.45 (5.63, 8.04) | 3.023 | 0.003 |
RBC count (× 106/μL), Mean ± SD | 4.46 ± 0.66 | 4.31 ± 0.61 | 4.53 ± 0.68 | 1.696 | 0.093 |
Hemoglobin (g/L), Mean ± SD | 132.95 ± 19.65 | 130.11 ± 17.77 | 134.23 ± 20.42 | 1.043 | 0.299 |
PLT (× 109/L), M(Q1, Q3) | 221.00 (189.75, 257.50) | 216.50 (179.25, 234.50) | 226.50 (193.50, 263.00) | − 1.155 | 0.248 |
LDL (mmol/L), M(Q1, Q3) | 2.83 (2.24, 3.38) | 2.78 (1.95, 3.41) | 2.83 (2.40, 3.34) | − 1.277 | 0.202 |
TC (mmol/L), Mean ± SD | 4.30 ± 1.02 | 4.20 ± 1.16 | 4.34 ± 0.95 | − 0.683 | 0.496 |
TRIG (mmol/L), M(Q1, Q3) | 1.19 (0.85, 1.64) | 1.10 (0.81, 1.58) | 1.21 (0.90, 1.66) | − 0.612 | 0.541 |
FIB (g/L), Mean ± SD | 2.58 ± 0.96 | 2.63 ± 0.84 | 2.56 ± 1.00 | 0.345 | 0.731 |
INR, M(Q1, Q3) | 1.02 (0.96, 1.08) | 1.04 (0.98, 1.11) | 1.00 (0.95, 1.06) | 1.911 | 0.056 |
Ca2+(mmol/L), M(Q1, Q3) | 2.11 (1.98, 2.19) | 2.02 (1.97, 2.14) | 2.13 (1.99, 2.20) | − 1.869 | 0.062 |
CRP (mg/L), M(Q1, Q3) | 2.00 (0.50, 5.59) | 2.14 (0.47, 6.69) | 1.92 (0.500, 5.51) | 0.155 | 0.877 |
Infarct location | NA | NA | |||
Right MCA territory (%) | 37 (31.90) | 18 (50.00) | 19 (23.75) | ||
Left MCA territory (%) | 48 (41.38) | 14 (38.88) | 34 (42.50) | ||
Right basal ganglia (%) | 7 (6.03) | 1 (2.78) | 6 (7.50) | ||
Left basal ganglia (%) | 10 (8.60) | 1 (2.78) | 9 (11.25) | ||
Brainstem (%) | 2 (1.73) | 1 (2.78) | 1 (1.25) | ||
Right cerebellum (%) | 2 (1.73) | 0 (0.00) | 2 (2.50) | ||
Left cerebellum (%) | 2 (1.73) | 0 (0.00) | 2 (2.50) | ||
Other (%) | 8 (6.90) | 1 (2.78) | 7 (8.75) | ||
Hyperdense area on mixed energy CT | |||||
volume (mm3), M(Q1, Q3) | 2342.00 (1632.00, 3267.00) | 2366.50 (1801.00, 3244.00) | 2143.00 (1546.50, 2938.50) | 0.754 | 0.459 |
HT type | NA | NA | |||
HI- 1 (%) | 11 (9.48) | 11 (30.56) | 0 | ||
HI-2 (%) | 4 (3.45) | 4 (11.11) | 0 | ||
PH-1 (%) | 10 (8.62) | 10 (27.77) | 0 | ||
PH-2 (%) | 6 (5.17) | 6 (16.67) | 0 | ||
SAH (%) | 1 (0.86) | 1 (2.78) | 0 | ||
Remote PH (%) | 4 (3.45) | 4 (11.11) | 0 | ||
SICH (%) | 11 (9.48) | 11 (30.56) | 0 | ||
mTICI | 5.882 | 0.053 | |||
2b (%) | 17 (14.65) | 9 (25.00) | 8 (10.00) | ||
2c (%) | 54 (46.56) | 12 (33.33) | 42 (52.50) | ||
3 (%) | 45 (38.79) | 15 (41.67) | 30 (37.50) | ||
Onset to thrombectomy (min), M(Q1, Q3) | 322.50 (180.00, 431.50) | 345.00 (240.00, 430.50) | 316.50 (176.25, 431.50) | 1.066 | 0.286 |
Onset to DECT (min), M(Q1, Q3) | 1508.00 (1249.00,1813.00) | 1447.00 (1176.75, 1825.75) | 1526.00 (1311.00, 1804.00) | − 0.513 | 0.608 |
Thrombectomy to DECT (min), M(Q1, Q3) | 1208 (838.75, 1417.5) | 1000.00 (737.75, 1333.50) | 1235.50 (1011.50, 1399.50) | − 1.805 | 0.071 |